- freely available
- re-usable
Mar. Drugs 2005, 3(2), 36-63; doi:10.3390/md302036
Article
Quality not Quantity: The Role of Marine Natural Products in Drug Discovery and Reverse Chemical Proteomics
Department of Chemistry & Biomolecular Sciences, Macquarie University, Sydney, NSW 2109 Australia
* Author to whom correspondence should be addressed.
Received: 15 April 2005 / Accepted: 30 May 2005 / Published: 1 June 2005
Abstract: Reverse chemical proteomics combines affinity chromatography with phage display and promises to be a powerful new platform technology for the isolation of natural product receptors, facilitating the drug discovery process by rapidly linking biologically active small molecules to their cellular receptors and the receptors’ genes. In this paper we review chemical proteomics and reverse chemical proteomics and show how these techniques can add value to natural products research. We also report on techniques for the derivatisation of polystyrene microtitre plates with cleavable linkers and marine natural products that can be used in chemical proteomics or reverse chemical proteomics. Specifically, we have derivatised polystyrene with palau’amine and used reverse chemical proteomics to try and isolate the human receptors for this potent anticancer marine drug.
Keywords: palau’amine; reverse chemical proteomics; phage display
Article Statistics
Click here to load and display the download statistics.Cite This Article
MDPI and ACS Style
Piggott, A.M.; Karuso, P. Quality not Quantity: The Role of Marine Natural Products in Drug Discovery and Reverse Chemical Proteomics. Mar. Drugs 2005, 3, 36-63.
AMA StylePiggott AM, Karuso P. Quality not Quantity: The Role of Marine Natural Products in Drug Discovery and Reverse Chemical Proteomics. Marine Drugs. 2005; 3(2):36-63.
Chicago/Turabian StylePiggott, Andrew M.; Karuso, Peter. 2005. "Quality not Quantity: The Role of Marine Natural Products in Drug Discovery and Reverse Chemical Proteomics." Mar. Drugs 3, no. 2: 36-63.
Mar. Drugs
EISSN 1660-3397
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert
